Demo Sign up Log In

Pdl Biopharma Inc (PDLI)

SG&A Expenses

$39.60M

TTM · Period ending: Sep 30, 2020 · USD

PDLI SG&A Expenses

Latest reported$39.60Mperiod endingSep 30, 2020

Latest reported$39.60Mperiod endingSep 30, 2020

PDLI SG&A Expenses ($5.60M → $39.60M)

Annual SG&A Expenses

High-resolution chart · PNG

PDLI sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc SG&A Expenses — Annual fiscal periods (USD)
Period ending	SG&A Expenses (USD)
Dec 31, 2019	54,080,000
Dec 31, 2018	62,559,000
Dec 31, 2017	63,324,000
Dec 31, 2016	40,328,000
Dec 31, 2015	36,090,000
Dec 31, 2014	34,914,000
Dec 31, 2013	29,755,000
Dec 31, 2012	25,469,000
Dec 31, 2011	16,155,000
Dec 31, 2010	133,896,000
Dec 31, 2009	21,064,000
Dec 31, 2008	51,544,000
Dec 31, 2007	67,367,000
Dec 31, 2006	120,856,000
Dec 31, 2005	82,386,000
Dec 31, 2004	31,806,000
Dec 31, 2003	27,613,000
Dec 31, 2002	19,093,000
Dec 31, 2001	15,726,000
Dec 31, 2000	12,110,000
Dec 31, 1999	9,800,000
Dec 31, 1998	8,700,000
Dec 31, 1997	6,600,000
Dec 31, 1996	5,600,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.